Single-Fraction Radiation Therapy for Localized Cutaneous T-Cell Lymphoma

Review Oncology

Mycosis Fungoides and Sezary Syndrome: Updates and Review of Current Therapy

Hiroaki Kamijo et al.

Summary: While most early-stage MF patients are treated with skin-directed therapies, advanced-stage MF/SS patients are usually treated with systemic treatments including biological or targeted therapies. Due to a lack of randomized controlled studies in the literature, it is necessary to investigate the preferable therapy for each MF/SS patient through comparative prospective trials.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)

添加到收藏夹

Article Dermatology

Primary cutaneous T-cell lymphomas in childhood and adolescence

Iris Wohlmuth-Wieser

Summary: Primary cutaneous lymphomas are extranodal non-Hodgkin lymphomas that predominantly affect older patients, but can occur in all age groups including children. Diagnosis requires collaboration between dermatologists, pediatric oncologists, and pathologists. Children with cutaneous lymphomas often present with early-stage disease and respond well to treatment with corticosteroids and phototherapy.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2021)

添加到收藏夹

Article Oncology

Cutaneous T-cell lymphomas-An update 2021

Werner Kempf et al.

Summary: CTCL, including MF and cutaneous CD30+ lymphoproliferative disorders, requires clinical-pathological correlation for diagnosis. Treatment is stage-adapted with options like UV-light therapies, corticosteroids, and targeted therapies. Novel therapies such as mogamulizumab, brentuximab vedotin, and histone deacetylase inhibitors have been introduced for better management.

HEMATOLOGICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology